Patients hospitalized for COVID-19 in 2021 may face bills in the thousands of dollars if their insurer no longer waives cost-sharing for these hospitalizations.
Dental opioid prescriptions are associated with an increased risk of overdose in both patients and their family members
Among publicly and privately insured patients undergoing dental procedures between 2014-2018, the risk of persistent opioid use was 1.0 percentage points higher in publicly insured patients compared with privately insured patients
In this mixed-methods study of U.S. youth, the vast majority reported using face coverings most or all of the time, and most were concerned about spreading COVID-19 to others
Just 1 in 5 dollars spent on 15 top-selling “partial orphan drugs” – those approved to treat both rare and common diseases – were for the rare diseases for which the sponsors of these drugs received lucrative orphan drug benefits.
Among privately and publicly insured patients aged 13-64 years undergoing dental procedures between 2013-2018, two-thirds of opioid prescriptions were for tooth extraction, a procedure for which opioids are no better than over-the-counter pain medications such as ibuprofen.
Among Medicare Advantage enrollees hospitalized for influenza in 2018, mean out-of-pocket spending was almost $1,000, suggesting that cost-sharing for COVID-19 hospitalizations may be substantial in this population if voluntary waivers of cost-sharing from insurers are allowed to expire.
Latest research from CHEAR Faculty Dr. Jeremy Adler
Dr. Chua and collaborators conducted an online survey of 1,193 parents of school-aged children in Illinois, Michigan, and Ohio to assess their plans for sending children to school during the 2020-2021 school year and to assess their views on 15 potential measures that might be implemented to reduce COVID-19 risk in schools.